Viewing nowCombinationDuo 5/160 mg
Valsartan 160mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Youyoung Pharmaceutical Co., Ltd.

MFDS item code 201308461 · Approved 2013.07.30 · Insurance code 648203650
Treatment of essential hypertension not controlled with monotherapy
Essential hypertension is a condition where blood pressure is persistently high, imposing a burden on the cardiovascular system. Amlodipine and valsartan function to lower blood pressure through vasodilation and blood pressure regulation, respectively. However, when blood pressure is not adequately controlled with monotherapy, the two drugs can be appropriately combined for more effective blood pressure management. Well-controlled blood pressure can reduce the risk of complications such as heart disease or stroke. These medications are used in the treatment of essential hypertension.
The recommended dose of this drug is 1 tablet once daily, taken with water, regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before administering this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this drug may be considered. ㆍ 5/80 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ 5/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ 10/160 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, this drug should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Use of this drug is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.
This medication can cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the active ingredients or similar medications, pregnant or nursing women, patients with severe kidney or liver impairment, and those with specific heart diseases should not use this medication. Individuals with low sodium or fluid levels in the body should correct their condition before taking this medication, and if symptoms of hypotension occur while taking it, they should seek appropriate measures immediately. Patients with high potassium levels should use caution when taking this medication and potassium-raising drugs together and should have their potassium levels checked regularly. Patients with impaired kidney function, kidney transplant recipients, those with a history of angioedema, heart failure, or recent myocardial infarction should exercise special caution when using this medication. As this medication lowers blood pressure, care should be taken while driving or operating machinery due to potential dizziness or fatigue. Patients taking other blood pressure medications, potassium-sparing diuretics, certain anti-inflammatory agents, heart medications, etc., may experience interactions, so consultation with a doctor or pharmacist is advisable. Women who are pregnant or planning to become pregnant should not use this medication, and nursing mothers are also advised to avoid it. Children under 18 years of age are not recommended to use this medication as its safety and efficacy have not been adequately established. Elderly patients may be recommended similar dosages as adults, but caution may be necessary depending on individual conditions. Overdosage of this medication can result in severe hypotension and heart-related issues, so the dosage should be strictly adhered to, and any unusual symptoms should prompt immediate medical attention.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, sensory disturbance, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle cramps, lethargy, polyuria, nocturia, erectile dysfunction, edema, pituitary edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disorder, peripheral neuropathy, muscle rigidity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux, neck pain, hypercholesterolemia, hypoglycemia, neuropathy, Stevens-Johnson syndrome, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should ideally be maintained at room temperature between 1 degree and 30 degrees.
Dark yellow oval film-coated tablets
30 tablets (10 tablets/PTP packaging x 3), 100 tablets (10 tablets/PTP packaging x 10), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Youyoung Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.